Welcome to our dedicated page for Delphx Cap Mkts news (Ticker: DPXCF), a resource for investors and traders seeking the latest updates and insights on Delphx Cap Mkts stock.
DelphX Capital Markets Inc. (DPXCF) provides advanced structured products for fixed income market participants, specializing in credit risk mitigation through instruments like collateralized put options and reference notes. This page serves as the definitive source for official company announcements and market-relevant updates.
Access real-time press releases covering strategic partnerships, product innovations, and financial performance. Investors will find critical updates on securities offerings, regulatory developments, and operational milestones that impact credit risk management strategies.
Our curated news collection enables institutional clients and analysts to track DelphX's progress in developing collateralized solutions while monitoring key initiatives through Quantem LLC subsidiary. Content spans earnings disclosures, technology implementations, and market expansion efforts.
Bookmark this resource to maintain awareness of DelphX's evolving role in creating transparent risk transfer mechanisms for fixed income dealers. Regular updates ensure you stay informed about developments affecting credit rating security products and related financial instruments.
DelphX Capital Markets (OTCQB: DPXCF) announced a non-binding letter of intent with Belgravia Hartford Capital to pursue the first anticipated commercial transaction using DelphX's Quantem Crypto Security (QCS), specifically a QCS-collateralized put option intended to protect corporate Bitcoin treasury holdings. The LOI is non-binding and conditioned on definitive documentation, regulatory approvals, market conditions, and customary closing conditions.
DelphX also announced a CFO transition: Simon Selkrig will return as CFO effective January 1, 2026. The board approved a grant of 2,875,000 stock options, exercisable at $0.08 with a two-year maturity.
DelphX (OTCQB: DPXCF, TSXV: DELX) closed a non-brokered private placement on December 22, 2025, issuing 1,250,000 units at C$0.04 per unit for gross proceeds of C$50,000. Each unit includes one common share and one warrant.
Each warrant is exercisable for one common share at $0.06 for two years from issuance. Completion is subject to TSX Venture Exchange approval. Securities are subject to a four-month plus one day hold period. DelphX intends to use net proceeds for working capital and corporate overhead.
DelphX (OTCQB: DPXCF) announced a non-brokered private placement of 1,250,000 units at C$0.04 per unit for gross proceeds of C$50,000. Each unit includes one common share and one warrant; each warrant is exercisable for one common share at $0.06 for two years from issuance. Completion is subject to TSX Venture Exchange approval and issued securities will be subject to a four-month plus one day hold period. DelphX intends to use net proceeds for working capital and corporate overhead.
DelphX (OTCQB: DPXCF; TSXV: DELX) closed a non-brokered unit private placement announced Nov 27, 2025, issuing 2,800,000 units at C$0.04 per unit for gross proceeds of C$112,000. Each unit comprises one common share and one warrant.
Each warrant allows purchase of one common share at $0.07 for two years from issuance. Completion remains subject to TSX Venture Exchange approval. Securities are subject to a four-month plus one day hold period. DelphX intends to use net proceeds for working capital and corporate overhead.
DelphX (OTCQB: DPXCF) announced a non-brokered private placement of 2,800,000 units at C$0.04 per unit for gross proceeds of C$112,000. Each unit includes one common share and one warrant exercisable at $0.07 for two years. Closing is subject to TSX Venture Exchange approval and a four-month-and-one-day hold period on securities. Net proceeds are intended for general corporate purposes.
DelphX also seeks TSXV approval to extend the exercise period of 5,422,221 warrants (exercise price $0.15) by one year to December 7, 2026. 1,611,111 of those warrants are held by related parties; the company says available exemptions under MI 61-101 apply.
DelphX (OTCQB: DPXCF) provided a shareholder update on its Quantem Crypto Securities (QCS) fully‑collateralized hedging solution on November 18, 2025. Since QCS marketing began in mid‑September 2025, Bitcoin moved from above US$115,000 to below US$90,000, highlighting demand for institutional hedges. QCS is described as fully collateralized, transparent, and structured to mitigate volatility and protect treasury assets.
The company says a U.S. primary dealer is evaluating a possible proof‑of‑concept and multiple digital‑asset treasuries are conducting due diligence and scenario testing, but implementation is not assured.
DelphX Capital Markets (OTCQB: DPXCF) closed a non-brokered private placement on November 14, 2025, issuing 1,200,000 units at C$0.05 per unit for gross proceeds of C$60,000. Each unit includes one common share and one warrant.
Each warrant is exercisable for one common share at $0.08 for two years from issuance. Completion remains subject to TSX Venture Exchange approval. Securities are subject to a hold period of four months plus one day. Net proceeds are intended for general corporate purposes.
DelphX (OTCQB: DPXCF; TSXV: DELX) intends to proceed with a non-brokered private placement of 1,200,000 units at C$0.05 per unit for gross proceeds of C$60,000. Each Unit comprises one common share and one warrant. Each warrant entitles the holder to buy one common share at C$0.08 for a two-year period from issuance. Completion is subject to TSX Venture Exchange approval. Securities issued will be subject to a four months plus one day hold period. DelphX intends to use net proceeds for general corporate purposes.
DelphX (OTCQB: DPXCF) intends to seek TSX Venture Exchange approval to extend the exercise period of 3,483,668 share purchase warrants issued Nov 1, 2023, exercisable at $0.20 per common share.
The proposed amendment would extend the warrants by one year to November 1, 2026; all other terms remain unchanged and the extension is subject to TSXV acceptance.
The company disclosed 866,667 warrants are held by related parties and classified the amendment as a related party transaction under MI 61-101 and TSXV Policy 5.9, while noting exemptions apply because the warrants' fair market value does not exceed 25% of market capitalization.
DelphX (OTCQB: DPXCF) closed a non‑brokered private placement on October 8, 2025, issuing 1,500,000 Units at C$0.05 per Unit for gross proceeds of C$75,000. Each Unit includes one common share and one warrant exercisable at $0.08 for two years.
An insider subscribed for 1,000,000 Units, triggering related‑party disclosure; DelphX relied on MI 61‑101 exemptions because the issuance and cash paid did not exceed 25% of market capitalization. Finder's fees of $3,500 and 70,000 finder's warrants (exercisable at $0.08 for two years) were issued. Securities are subject to a four months plus one day hold period and TSXV approval.
FAQ
What is the current stock price of Delphx Cap Mkts (DPXCF)?
What is the market cap of Delphx Cap Mkts (DPXCF)?
